These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
663 related articles for article (PubMed ID: 20678902)
1. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors. Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902 [TBL] [Abstract][Full Text] [Related]
2. Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth. Dykhuizen EC; May JF; Tongpenyai A; Kiessling LL J Am Chem Soc; 2008 May; 130(21):6706-7. PubMed ID: 18447352 [TBL] [Abstract][Full Text] [Related]
3. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase. Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454 [TBL] [Abstract][Full Text] [Related]
4. Chemical probes of UDP-galactopyranose mutase. Carlson EE; May JF; Kiessling LL Chem Biol; 2006 Aug; 13(8):825-37. PubMed ID: 16931332 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM). Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094 [TBL] [Abstract][Full Text] [Related]
7. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
8. Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach. Nayak T; Jena L; Waghmare P; Harinath BC Int J Mycobacteriol; 2018; 7(1):61-68. PubMed ID: 29516888 [TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. Khan A; Sarkar S; Sarkar D Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548 [TBL] [Abstract][Full Text] [Related]
10. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues. Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471 [TBL] [Abstract][Full Text] [Related]
11. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues. van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles. Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384 [TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Inhibitors of UDP-Galactopyranose Mutase by Structure-Based Virtual Screening. Karunan Partha S; Sadeghi-Khomami A; Cren S; Robinson RI; Woodward S; Slowski K; Berast L; Zheng B; Thomas NR; Sanders DA Mol Inform; 2011 Oct; 30(10):873-83. PubMed ID: 27468107 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP. Partha SK; van Straaten KE; Sanders DA J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401 [TBL] [Abstract][Full Text] [Related]
16. Identification of inhibitors for UDP-galactopyranose mutase. Soltero-Higgin M; Carlson EE; Phillips JH; Kiessling LL J Am Chem Soc; 2004 Sep; 126(34):10532-3. PubMed ID: 15327298 [TBL] [Abstract][Full Text] [Related]
17. Identification of inhibitors of UDP-galactopyranose mutase Fu J; Fu H; Xia Y; N'Go I; Cao J; Pan W; Vincent SP Org Biomol Chem; 2021 Mar; 19(8):1818-1826. PubMed ID: 33565547 [TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique. Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059 [TBL] [Abstract][Full Text] [Related]
19. Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose. Eppe G; Peltier P; Daniellou R; Nugier-Chauvin C; Ferrières V; Vincent SP Bioorg Med Chem Lett; 2009 Feb; 19(3):814-6. PubMed ID: 19119008 [TBL] [Abstract][Full Text] [Related]
20. Identification of eukaryotic UDP-galactopyranose mutase inhibitors using the ThermoFAD assay. Martín Del Campo JS; Eckshtain-Levi M; Sobrado P Biochem Biophys Res Commun; 2017 Nov; 493(1):58-63. PubMed ID: 28919416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]